Introduction {#sec1}
============

Endotoxin-induced acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS), are consequences of acute respiratory failure. Although the mortality rate associated with this syndrome has declined recently, ARDS remains one of the major causes of pulmonary and non-pulmonary morbidity in patients after hospital discharge \[[@cit0001], [@cit0002]\], and the mechanism for ALI has not been fully established. Studies in recent years have shown that the accumulation of inflammatory cell polymorphonuclear neutrophils (PMNs) in lung tissue \[[@cit0003]\], which is mediated through integrins such as CD11b and its ligand intercellular adhesion molecule-1 (ICAM-1), is the key pathological basis of endotoxin-induced ALI. Excessive infiltration of PMNs in response to infection causes an imbalance between inflammatory and anti-inflammatory cytokines \[[@cit0003]-[@cit0005]\], as well as abnormal vascular reactivity in the pulmonary circulation \[[@cit0006], [@cit0007]\], which further stimulate immune responses and ultimately promote the development of ALI.

Gaseous messenger molecules (signal transmitters), including nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H~2~S), played important roles in both physiological and pathological conditions, including those of the inflammatory response \[[@cit0008]-[@cit0011]\]. In recent years, interest has been directed towards another naturally occurring gas, sulfur dioxide (SO~2~). SO~2~ is a common gaseous pollutant in the atmosphere, generally regarded as an environmental toxin. Epidemiological investigations have found that SO~2~ exposure correlated with development of cardiovascular diseases in humans \[[@cit0012]\]. In addition, experimental studies have revealed that SO~2~ and its derivatives, sulfite and bisulfite, could act as systemic toxic substances, capable of affecting multiple organs in mammals \[[@cit0013]-[@cit0016]\]. Endogenous SO~2~ can be produced during the normal processing of sulfur-containing amino acids such as L-cysteine *in vivo*, which is first oxidized to L-cysteine sulfinate, and the latter can develop through transamination by aspartate aminotransferase into β-sulfinylpyruvate, which decomposes spontaneously to pyruvate and SO~2~, and it had been shown that the SO~2~/aspartate aminotransferase (AAT) pathway could regulate vascular activities and was involved in the inflammatory response in vascular and lung tissues \[[@cit0017], [@cit0018]\]. In addition, our previous study suggested that SO~2~ attenuates LPS-induced ALI via enhancing apoptosis of PMNs \[[@cit0019]\]. So, in this study, we decided to investigate and validate the hypothesis that endogenous gaseous SO~2~ may also act as a messenger molecule that could regulate inflammatory responses and vascular reactivity of pulmonary arteries (PAs), which are particularly involved in ALI.

Material and methods {#sec2}
====================

Preparation of experimental animal model {#sec2.1}
----------------------------------------

All experiments were approved by the Animal Ethics Committee of the National University of China (No. 0126), and all experiments were carried out in accordance with established guiding principles for animal research. Forty-eight adult male Sprague Dawley rats (250\~300 g) were randomly divided into six treatment groups: control (*n* = 8), control + SO~2~ (*n* = 8), control + ~L~-aspartic acid-β-hydroxamate (HDX) (*n* = 8), LPS (*n* = 8), LPS + SO~2~ (*n* = 8) and LPS + HDX (*n* = 8). For this experiment, rats were anesthetized with ether inhalation, which did not influence the patterns of inflammation and SO~2~ production (data not shown). Control rats were instilled intratracheally with 200 µl of normal saline, while LPS-treated animals were instilled intratracheally with 200 µl of LPS (*Escherichia coli* 055:B5; 100 µg/100 g of body weight, dissolved in 200 µl of saline, Sigma, St. Louis, MO, USA). HDX, an inhibitor of endogenous SO~2~ generating enzymes, was injected intraperitoneally (i.p., 3.7 mg/kg, Sigma) into rats in the LPS + HDX group 30 min before LPS instillation. The HDX dose used was based on observations of SO~2~-independent effects in a previous study \[[@cit0020]\] and our own preliminary experiment. The same dosage of HDX was injected i.p. into rats of the control + HDX group. For rats in the control + SO~2~ group and LPS + SO~2~ group, SO~2~ saline solution (25 µmol/kg) was injected i.p. 30 min before saline or LPS instillation. The concentration of SO~2~ also was based on a previous study \[[@cit0020]\] and our preliminary experiment. An identical volume of saline was injected into rats of the control group and LPS group.

The SO~2~ solution was freshly prepared before each experiment by bubbling saline with pure SO~2~ gas (purity: 99.99%, Beijing He-Pu-Bei-Fen Gas Company, Ltd., Beijing, China) and diluting it to achieve SO~2~ concentrations required according to the previous method \[[@cit0021]\]. Six hours after the LPS instillation, animals were sacrificed by an i.p. injection of a lethal dose of pentobarbitone (90 mg/kg). Blood samples were taken from the right ventricles using heparinized syringes and then centrifuged (4000 × g, 10 min, 0-4°C). Thereafter, plasma and lung tissue specimens were stored at --80°C for subsequent measurement of SO~2~ concentrations.

Measurement of pulmonary arterial pressure {#sec2.2}
------------------------------------------

Six hours after the LPS instillation, rats were anesthetized with pentobarbitone (50 mg/kg, i.p.). A silicone catheter (outer diameter, 0.9 mm) was introduced into the right jugular vein by venotomy. It was passed across the tricuspid valve and right ventricle into the PA. The distal end of the catheter was connected to a PowerLab system via a pressure transducer (model Gould P23Db, AD Instruments, Sidney, Australia) for pulmonary arterial pressure (PAP) measurements.

Determination of PA reactivity {#sec2.3}
------------------------------

After PAP measurements, the PAs were rapidly isolated and placed in a 4°C modified Krebs-Henseleit (K-H) solution containing the following (in mM): NaCl 118.0, KCl 4.7, CaCl~2~ 2.5, MgSO~4~ 1.2, NaHCO~3~ 25.0, KH~2~PO~4~ 1.2 and glucose 11.0, gassed with 95% O~2~ and 5% CO~2~ (pH 7.2-7.4). The PA adventitia was cleared and cut into 3-mm width rings. PA rings were mounted in organ chambers filled with 6 ml K-H solution (gassed with 95% O~2~ and 5% CO~2~, 37 ±0.5°C, pH 7.4), which was supplemented with 10^-5^ mol/l indomethacin. At the beginning of the experiment, each PA ring was stretched to its optimal resting tension, which was achieved stepwise until the active contraction of the PA ring in response to 100 mM KCl reached a plateau. The optimal resting tension of the rat PAs was approximately 1.0 g. The vessels were allowed to equilibrate for 1 h, and the K-H solution was changed every 15 min. The contractile responses were performed by cumulative addition of phenylephrine (PE, 10^-8^-10^-5^M, Sigma) and expressed as a percentage of the response to 100 mM KCl. The viability and integrity of the arterial endothelium were estimated by the analysis of the relaxant response to cumulative addition of acetylcholine (ACh, 10^-8^-10^-5^ M, Sigma) or sodium nitroprusside (SNP, 10^-9^-10^-6^M, Sigma) after precontraction with 10^-6^ M PE.

Preparation and morphometric analysis of lung tissue {#sec2.4}
----------------------------------------------------

After the PAP was measured, the thoracic cavity was opened. One of the lung lobes was removed and fixed in 4% (wt/vol) paraformaldehyde at 30 cm H~2~O pressure. After routine processing and paraffin embedding, lung tissues were sliced into thin sections (5-µm thickness) and stained with hematoxylin and eosin (H&E). Based on the degree of cellular and protein exudation and tissue hemorrhage, the extent of lung injury was determined by assigning a score between 0 (normal) and 3 (severely damaged) for each parameter as previously reported \[[@cit0022]\]. The severity of lung injury was scored by two pulmonologists, who were blinded to the treatments. Ten fields were randomly selected from three lung tissue sections per rat and examined under a microscope at 200× magnification. The degree of cellular and protein exudation and tissue hemorrhage per rat was determined by adding the scores from 10 randomly selected fields. The total lung injury score per rat was determined by the sum of three individual scores for alveolar cellular and protein exudation and tissue hemorrhage.

Determination of myeloperoxidase activity in lung tissue {#sec2.5}
--------------------------------------------------------

Tissue samples were homogenized in 20 mM phosphate buffer (pH 7.4) and centrifuged (13,000 × g, 10 min, 4°C). The resulting pellets were resuspended in 50 mM phosphate buffer (pH 6.0) containing 0.5% (wt/vol) hexadecyltrimethylammonium bromide (Sigma). The suspension was then subjected to four cycles of freezing and thawing and further disrupted by sonication (40 s). The samples were then centrifuged (13,000 × g, 5 min, 4°C), and the supernatants were collected for immediate use in the myeloperoxidase (MPO) assay. The MPO reaction mixture consisted of the supernatant (50 µl), 1.6 mM tetramethyl-benzidine (Sigma), 80 mM sodium phosphate buffer (pH 5.4) and 0.3 mM hydrogen peroxide. This mixture was incubated at 37°C for 110 s, and the reaction was terminated by addition of 50 µl of 0.18 M H~2~SO~4~. The absorbance was measured at 405 nm and normalized by the DNA content of the original tissue sample \[[@cit0023]\]. Results were expressed as the fold change in MPO activity in the test sample over that of the control.

Measurements of IL-1β, IL-6 and IL-10 levels in lung tissue {#sec2.6}
-----------------------------------------------------------

Six hours after the LPS instillation, the lower lobes of the right lung were homogenized and centrifuged. The supernatants were collected for testing IL-1β, IL-6 and IL-10 concentrations. Blood samples (4 ml from each rat) from each group were collected in heparinized tubes by jugular vein catheterization and centrifuged (3,000 × g, 10 min). Cytokines levels were assayed using a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) following the manufacturer's instructions (Diaclone, Fleming, France). Briefly, samples or standards for IL-1β, IL-6 or IL-10 were added in duplicate to the ELISA plate in 100 µl per well. After incubation at 37°C for 1 h, samples were removed, and the plates were washed five times with a wash buffer (10 mmol/l PBS, pH 7.4, and 0.1% Tween-20). Blotted plates were dried by tapping upside down on filter paper. Biotinylated anti-rat IL-1β, IL-6 or IL-10 (100 µl) was added to each well of the plates, which were incubated for 30 min at 37°C. After five additional washes, 100 µl of horseradish peroxidase (HRP) was added to each well, and the plates were incubated for another 30 min at 37°C. Following a final series of five washes, 100 µl of tetramethylbenzidine (TMB) substrate was added to each well with gentle shaking for 10 s. The mixture was then incubated in the dark for 30 min at room temperature. The reaction was terminated by adding 100 µl of stop solution to each well, and the optical density (OD) at 450 nm was measured with an ELISA reader (Bio-Rad, Hercules, CA, USA). Cytokine concentrations were obtained by plotting sample OD values against those of the corresponding standard curve.

Determination of SO~2~ content in lung tissue {#sec2.7}
---------------------------------------------

The right lung samples were homogenized and immediately processed for analysis. Each homogenate (100 µl) was mixed with 70 µl of 0.212 mmol/l sodium borohydride in 0.05 mol/l Tris-HCl (pH 8.5) and incubated at room temperature for 30 min. The samples were then mixed with 10 µl of 70 mmol/l monobromobimane in acetonitrile. After incubation for 10 min at 42°C, 40 µl of 1.5 mmol/l perchloric acid solution was added to the mixture, followed by vortex mixing. The protein precipitates were removed by centrifugation at 12,400 × g for 10 min at room temperature. The supernatant was immediately neutralized by adding 10 µl of 2 mmol/l Tris (pH 3.0), followed by gentle mixing and centrifugation again at 12,400 × g for 10 min. Ten microliters of the neutralized supernatant was injected onto a high performance liquid chromatography (HPLC) column (Hitachi 655A-11 HPLC system, Tokyo, Japan). All procedures of the tissue sample preparation were completed within 2 h after homogenization. Samples were resolved on a 4 × 250 mm C8 reversed phase column (5 µm packing, GL Science, Tokyo, Japan). The column was equilibrated with methanol/acetic acid/water (5.00 : 0.25 : 94.75, by volume, pH 3.4) and developed with a gradient of methanol at a flow rate of 0.8 ml/min as follows: 0-5 min, 30 ml/l; 5-13 min, 30-500 ml/l; 13-30 min, 350-620 ml/l; 30-31 min, 620-1000 ml/l; 31-39 min, 1000 ml/l; 39-40 min, 1000-30 ml/l; and 40-46 min, 30 ml/l. Sulfite-bimane was detected by excitation at 390 nm and emission at 472 nm using a cut-off filter and eluted at the methanol concentration of 45 ml/l \[[@cit0024]\].

Determination of AAT activity in lung tissue {#sec2.8}
--------------------------------------------

AAT activity in lung tissues was determined using the UniCel DxC 800 Synchron Clinical System (Beckman Coulter, Inc., Fullerton, CA, USA). The lung tissues of rats were homogenized with 0.01 mol/l PBS (weight : volume, 1 : 10). Protein precipitates were removed by centrifugation at 2,500 × g for 10 min at room temperature. The supernatant was used to detect AAT activity by the Reitman method, and tissue proteins were analyzed by Coomassie Blue staining.

Western blotting analysis {#sec2.9}
-------------------------

After homogenization and lysing of rat lung tissues, equal amounts of proteins were boiled, separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred to a polyvinylidene difluoride (PVDF) membrane. Non-specific antibody binding was blocked by washing with Tris-buffered saline (TBS) containing 5% non-fat milk for 1 h. The membranes were then washed twice with PBST (0.01 M PBS mixed with 0.1% Tween-20) and incubated with the primary antibody for 1 h. The following primary antibodies were used (all from Santa Cruz unless otherwise specified): rabbit antibodies to ICAM-1 (1 : 1,000 dilution), CD11b (1 : 1,000 dilution), ERK (1 : 1,000 dilution), phosphorylated ERK (p-ERK, 1 : 2,00 dilution), Raf-1 (1 : 2,00 dilution) and MEK-1 (1 : 2,00 dilution); and a mouse antibody to β-actin (1:10,000, Abcam, Cambridge, UK). After washing with PBST, the membranes were incubated with biotin-labeled anti-rabbit IgG for ICAM-1, CD11b, ERK, p-ERK, Raf-1 or MEK-1 (diluted 1 : 4,000 in 0.01 M PBS, Chemicon, Billerica, MA, USA) and biotin-labeled anti-mouse IgG for β-actin (diluted 1 : 4,000 in 0.01 M PBS, KPL, Gaithersburg, MD, USA) for 1 h at 37°C. After washing with PBST again, the filters were incubated with HRP-conjugated streptavidin (diluted 1 : 4,000 in 0.01 M PBS, Zymed, Carlsbad, CA, USA) for 1 h at 37°C. The immunoreactions were visualized using an ECL detection kit (Pierce, Thermo Scientific, Waltham, MA, USA). The X-ray film was scanned using an image documentation system (Labworks Inc., Costa Mesa, CA, USA). The integral optical density (IOD) of each band was measured using the AlphaImager 2200 gel image analyzing system (Genetic Technologies, Miami, FL USA). Changes in the relative content of ICAM-1, CD11b, ERK, p-ERK, Raf-1 and MEK-1 protein were represented by the ratio of the IOD of each protein band to that of β-actin.

Statistical analysis {#sec2.10}
--------------------

All data were calculated as means ±SD. Comparisons between groups were performed using analysis of variance (ANOVA), followed by the Student-Newman-Keuls test, using the SPSS 13.0 statistical analysis software. Statistical significance was accepted when *p* \< 0.05. The optical density data from the Western blotting analysis were determined to be normally distributed at the α level of 0.05 and with the statistical power of 0.9.

Results {#sec3}
=======

Induction of ALI is associated with decrease in SO~2~ concentration {#sec3.1}
-------------------------------------------------------------------

LPS-induced lung injury is indicated by MPO activity, a marker of tissue neutrophil infiltration, and histological changes as well as cytokine changes. As expected, lung MPO activity (*p \<* 0.01, [Fig. 1](#f0001){ref-type="fig"}) and the IL-1β, IL-6 and IL-10 protein levels were significantly elevated after LPS treatment (*p \<* 0.01, [Fig. 2A-2C](#f0002){ref-type="fig"}), compared with the control group. Characteristic morphological changes in the lung also suggested inflammatory damage. The lung sections from rats with ALI induced by LPS exhibited interstitial edema, alveolar thickening and severe leukocyte infiltration in the interstitium and alveoli. Therefore, the total lung injury score was elevated significantly by LPS treatment (*p \<* 0.01, [Fig. 3](#f0003){ref-type="fig"}). Furthermore, the mean PAP of the ALI rat group was increased significantly after LPS treatment (*p \<* 0.01, [Fig. 4](#f0004){ref-type="fig"}). Moreover, LPS-induced lung injury was accompanied by significantly reduced AAT activity (*p* \< 0.05, [Fig. 5A](#f0005){ref-type="fig"}) and SO~2~ concentration (*p* \< 0.05, [Fig. 5B](#f0005){ref-type="fig"}) in the lung, compared with the control group. In addition, compared with control rats, administration of HDX (3.7 mg/kg) 30 min before saline intratracheal instillation decreased AAT activity (*p* \< 0.05, [Fig. 5A](#f0005){ref-type="fig"}), which caused a significant reduction in SO~2~ concentration in the rat lung (*p* \< 0.01, [Fig. 5B](#f0005){ref-type="fig"}). Meanwhile the lung MPO activity (*p* \< 0.05, [Fig. 1](#f0001){ref-type="fig"}), lung inflammatory response (*p* \< 0.01, [Fig. 2A-2C](#f0002){ref-type="fig"}) and mean PAP (*p* \< 0.05, [Fig. 4](#f0004){ref-type="fig"}) were all significantly higher than those of rats intratracheally instilled with saline. HDX administration also produced histological evidence of lung injury, resulting in a significantly higher total lung injury score relative to the control (*p* \< 0.01, [Fig. 3](#f0003){ref-type="fig"}).

![Effects of SO2 on myeloperoxidase (MPO) activity in rat lung tissues. Data are presented as the mean ±SD (*n* = 8 in each group); \* *p* \< 0.05, \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, compared with LPS group](CEJI-44-89593-g001){#f0001}

![IL-1β (**A**), IL-6 (**B**) and IL-10 (**C**) concentrations in rat lung tissues determined by ELISA. Data are presented as the mean ±SD (*n* = 8 in each group); \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g002){#f0002}

![Total lung injury score of rats in different groups. Data are presented as the mean ±SD (n = 8 in each group); \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g003){#f0003}

![Mean pulmonary artery pressure (mPAP) of rats. Data are presented as the mean ±SD (*n* = 8 in each group); \* *p* \< 0.05, \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g004){#f0004}

![AAT activity (**A**) and SO~2~ content (**B**) in rat lung tissues. Data are presented as the mean ±SD (*n* = 8 in each group); \* *p* \< 0.05, \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g005){#f0005}

Treatment with HDX attenuates SO~2~ formation and aggravates lung injury induced by LPS {#sec3.2}
---------------------------------------------------------------------------------------

Administration of HDX (3.7 mg/kg) 30 min before the LPS intratracheal instillation decreased AAT activity (*p* \< 0.05, [Fig. 5A](#f0005){ref-type="fig"}) and caused a significant reduction in SO~2~ concentration in the lungs of rats with ALI (*p* \< 0.01, [Fig. 5B](#f0005){ref-type="fig"}). Endogenous SO~2~ formation blocked by HDX injection also caused a further and pronounced rise in lung MPO activity in the LPS-induced injured lung compared with the effect of saline injection (*p* \< 0.05, [Fig. 1](#f0001){ref-type="fig"}). Pretreatment with HDX before LPS significantly aggravated lung inflammatory responses, as evidenced by significantly increased IL-1β and IL-6 protein levels and a decreased IL-10 protein level in lung tissues (*p* \< 0.05 or *p* \< 0.01, [Fig. 2A-2C](#f0002){ref-type="fig"}). Moreover, the HDX administration also produced histological evidence of more severe lung injury and, therefore, a significantly higher total lung injury score resulting from the increased pulmonary congestion, red blood cells, leukocyte infiltration and alveolar wall thickness (*p* \< 0.05, compared with saline injection; [Fig. 3](#f0003){ref-type="fig"}). In addition, administration of HDX also significantly increased the mean PAP of the ALI rat group relative to that of the saline injected group (*p* \< 0.01, [Fig. 4](#f0004){ref-type="fig"}).

Treatment with SO~2~ saline solution attenuates LPS-induced lung injury {#sec3.3}
-----------------------------------------------------------------------

To directly investigate the potential anti-inflammatory role of SO~2~ in ALI, a 25 µmol/kg SO~2~ saline solution was injected into the animals 30 min before LPS instillation. We found that SO~2~ pretreatment in both control rats and ALI rats resulted in a significant increase in SO~2~ concentrations in the lung (*p* \< 0.05 or *p* \< 0.01, [Fig. 5B](#f0005){ref-type="fig"}), while the AAT activity in the lung did not change (*p* \> 0.05, [Fig. 5A](#f0005){ref-type="fig"}). Administration of the SO~2~ saline solution mitigated the inflammation and damage caused by LPS in the lung. Compared with saline-injected rats, exogenous SO~2~ from the injected SO~2~ saline solution caused a pronounced decrease in MPO activity in the lung at 6 h after LPS intratracheal instillation (*p* \< 0.05, [Fig. 1](#f0001){ref-type="fig"}). We also found that injection of the SO~2~ saline solution 30 min before LPS instillation led to significant decreases in IL-1β and IL-6 levels, but an increase in the IL-10 level in lung tissues (*p* \< 0.01, [Fig. 2A-2C](#f0002){ref-type="fig"}). Furthermore, administration of SO~2~ saline solution attenuated the histological damage in the lung that was induced by LPS, consequently significantly lowering the total lung injury score (*p* \< 0.01, compared with saline injection; [Fig. 3](#f0003){ref-type="fig"}). Moreover, compared with the LPS group, the mean PAP was lower in the LPS + SO~2~ group (*p* \< 0.05, [Fig. 4](#f0004){ref-type="fig"}). In addition, no statistically significant changes were found between the control + SO~2~ group and the control group (*p* \> 0.05, [Figs. 1-4](#f0001){ref-type="fig"}).

ICAM-1 and CD11b protein expression in lung tissue by Western blotting {#sec3.4}
----------------------------------------------------------------------

Expression levels of ICAM-1 and CD11b proteins in the lung tissues of rats in the LPS group were both higher than those in the control group (both *p* \< 0.01, [Fig. 6](#f0006){ref-type="fig"}). In the LPS + SO~2~ group, the levels of both ICAM-1 and CD11b decreased when compared with the LPS group (*p* \< 0.05 or *p* \< 0.01, respectively, [Fig. 6](#f0006){ref-type="fig"}). However, when treated with HDX, the rats showed increased expression of ICAM-1 and CD11b proteins in the lung tissue of the LPS group (both *p* \< 0.01, [Fig. 6](#f0006){ref-type="fig"}); meanwhile, these proteins did not change in the control + SO~2~ group (*p* \> 0.05, [Fig. 6](#f0006){ref-type="fig"}) but were elevated in the control + HDX group compared with the control group (*p* \< 0.05 or *p* \< 0.01, respectively, [Fig. 6](#f0006){ref-type="fig"}).

![CD11b and intercellular adhesion molecule-1 (ICAM-1) protein expression by Western blot analysis (**A**) and densitometric analysis (**B**) in different groups. Data are presented as the mean ±SD (*n* = 6 in each group); \* *p* \< 0.05, \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g006){#f0006}

Raf-1 and MEK-1 expression in lung tissue by Western blotting {#sec3.5}
-------------------------------------------------------------

Compared with the control group, the expression of Raf-1 and MEK-1 proteins in the LPS group rats clearly rose (*p* \< 0.05 and *p* \< 0.01, respectively, [Fig. 7](#f0007){ref-type="fig"}); however, these proteins in rats of the LPS + SO~2~ group decreased compared with the LPS group (*p* \< 0.05 and *p* \< 0.01, respectively, [Fig. 7](#f0007){ref-type="fig"}). The expression of Raf-1 and MEK-1 proteins did not change in the control + SO~2~ group (*p* \> 0.05, [Fig. 7](#f0007){ref-type="fig"}), while it increased significantly in the control + HDX group compared with the control (*p* \< 0.05 and *p* \< 0.01, respectively, [Fig. 7](#f0007){ref-type="fig"}).

![Raf-1 and MEK-1 protein expression by Western blotting analysis (**A**) and densitometric analysis (**B**) in different groups. Data are presented as the mean ±SD (*n* = 6 in each group); \* *p* \< 0.05, \*\* *p* \< 0.01, compared with control group, \# *p* \< 0.05, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g007){#f0007}

Expression of p-ERK/ERK in lung tissue by Western blotting {#sec3.6}
----------------------------------------------------------

Compared with the control group, expression of p-ERK in rats of the LPS group clearly increased (*p* \< 0.01, [Fig. 8](#f0008){ref-type="fig"}). Compared with the LPS group, p-ERK expression in rats of the LPS + SO~2~ group decreased (*p* \< 0.01, [Fig. 8](#f0008){ref-type="fig"}). SO~2~ did not alter, while HDX, as an inhibitor of endogenous production of SO~2~, significantly increased the expression of p-ERK protein in rats undergoing endotracheal instillation with normal saline (*p* \< 0.05, [Fig. 8](#f0008){ref-type="fig"}). There was no significant difference in ERK expression in the lung of rats among the six groups (*p* \> 0.05, [Fig. 8](#f0008){ref-type="fig"}).

![ERK and p-ERK protein expression by Western blotting analysis (**A**) and densitometric analysis (**B**) in different groups. Data are presented as the mean ±SD (*n* = 6 in each group); \* *p* \< 0.05, \*\* *p* \< 0.01, compared with control group, \#\# *p* \< 0.01, compared with LPS group](CEJI-44-89593-g008){#f0008}

Determination of PA tension and endothelial function {#sec3.7}
----------------------------------------------------

PAs were mounted in organ chambers to test the contractile response to PE (10^-8^\~10^-5^M). No differences were found in the responses to this vasoconstrictor among each of the six groups (data not shown).

The endothelial function was tested in endothelium intact PA preconstricted with PE (10^-6^M). Analysis of the concentration-response curves to the endothelium-dependent vasodilator ACh showed no significant change between the control group and the control + SO~2~ group (*p* \> 0.05, [Fig. 9](#f0009){ref-type="fig"}). However, the curves significantly shifted to the right both in the LPS group and the control + HDX group of rats when compared with control rats (*p* \< 0.01, [Fig. 9](#f0009){ref-type="fig"}). Moreover, no changes were found in the response to the endothelium-independent vasodilator SNP in PA among the LPS, control + HDX and control groups of rats (data not shown). Analysis of the vessel tension and endothelial function data showed no significant change in the PA endothelium from rats of the control + SO~2~ group compared with the control group ([Figs. 10A and 10B](#f0010){ref-type="fig"}). However, significant structural injury of the PA endothelium was found in the control + HDX group ([Fig. 10C](#f0001){ref-type="fig"}) and the LPS group ([Fig. 10D](#f0001){ref-type="fig"}) compared to control rats.

![Endothelium-dependent relaxation responses to acetylcholine (ACh) in PAs. Data are presented as the mean ±SD (*n* = 8 in each group); \*\* *p* \< 0.01, compared with control group, \#\# *p* \< 0.01, compared with LPS group (PE -- phenylephrine)](CEJI-44-89593-g009){#f0009}

![Scanning electron micrographs of rat PA endothelium in the six groups (1500×). **A**) Control group; vascular endothelial cells appeared flat. **B**) Control + sulfur dioxide (SO2) group; the plasma membrane of a few endothelial cells was slightly irregular. **C**) Control + hydroxamate (HDX) group; vascular endothelial cells were swollen. **D**) LPS group; some vascular endothelial cells were swollen, and some cells were even degenerated. **E**) LPS + SO2 group; plasma membranes of vascular endothelial cells were relatively even and appeared intact. **F**) LPS + HDX group: some vascular endothelial cells were swollen, and some cells were even severely degenerated (HDX --)](CEJI-44-89593-g010){#f0010}

Furthermore, the relaxation of PA to ACh showed a significant increase in the LPS + SO~2~ group, but a decrease in the LPS + HDX group, compared with the LPS group (*p* \< 0.01, [Fig. 9](#f0009){ref-type="fig"}). Correspondingly, structural changes of the PA endothelium were alleviated in the LPS + SO~2~ group ([Fig. 10E](#f0001){ref-type="fig"}), but aggravated in the LPS + HDX group ([Fig. 10F](#f0001){ref-type="fig"}), compared with the control group.

Discussion {#sec4}
==========

In this study, we demonstrated that SO~2~ markedly reduced the inflammatory response of ALI induced by LPS, likely by down-regulating Raf-1, MEK-1 and p-ERK during ALI. It is likely that the down-regulated SO~2~/AAT pathway is involved in the underlying mechanism(s) responsible for lung injury induced by LPS. Excessive and uncontrolled inflammatory responses within the lung as well as PAH can complicate the clinical course of ALI induced by endotoxin. Recent research indicates that SO~2~ may be produced endogenously in vessels and lungs and regulates both vascular reactivity \[[@cit0021], [@cit0025]\] and inflammatory responses \[[@cit0003], [@cit0019], [@cit0026]\]. SO~2~ and its hydrated form, sulfite/bisulfite, are generated through the normal processing of sulfur-containing amino acids such as L-cysteine, and AAT can be a key enzyme in controlling the endogenous production of SO~2~. Exogenous and endogenous SO~2~ have been shown to exist in plasma and tissue in the form of sulfite-bimane (SO~3~ ^2-^ and HSO~3~ ^-^). Thus, the level of sulfite-bimane may represent SO~2~ content.

In this study, the LPS + SO~2~ group and LPS + HDX group were included in the experimental design to determine whether the down-regulated AAT/SO~2~ pathway is involved in the development of LPS-induced lung injury. The microstructural analysis in the LPS group showed significant lung injury in rats exposed to LPS for 6 h. Interestingly, the SO~2~ content and AAT activity in lung tissues decreased after LPS stimulation. Under identical LPS exposure conditions, rats of the LPS + SO~2~ group showed increased SO~2~ content in lung tissues, whereas the degree of lung injury clearly decreased. However, after treatment with HDX, an AAT inhibitor, the SO~2~ content in lung tissues decreased, while the lung injury was aggravated significantly. The results suggested that down-regulation of the SO~2~/AAT pathway may be involved in the development of ALI. Interestingly, the results shown in [Fig. 5A](#f0005){ref-type="fig"} suggest that HDX produced only a modest effect on AAT activity, while other variables were much more potently affected (e.g., total lung injury). This observation may be due to the non-specific inhibition of AAT by HDX, although it has been used primarily as an AAT inhibitor in other studies \[[@cit0027]\]. However, since the SO~2~ concentration was much more potently affected than AAT activity by HDX in our present study (see [Fig. 5B](#f0005){ref-type="fig"}), we can reasonably speculate that HDX inhibited the production of SO~2~ at least in part through an AAT-independent mechanism. Of course, further study would be needed to discern the extent of the contribution of AAT-independent effects to the pattern of injury observed.

PAH is important in the pathogenesis of ALI caused by LPS \[[@cit0028]\]. In this study, the mean PAP was clearly increased in the LPS-treated groups; meanwhile, SO~2~ could depress the mean PAP, whereas HDX could significantly augment it in ALI rats. The vessel tension and ultrastructural analyses showed that rats exposed to LPS for 6 h sustained endothelial injury and exhibited significantly decreased endothelium-dependent relaxation, which could be reversed by SO~2~ but aggravated by HDX. Our data suggest that SO~2~ may mitigate PAH-induced by LPS through regulation of the activity in the PA. Nevertheless, the underlying mechanism by which SO~2~ modulates activity in the PA in ALI warrants further investigation. Interactions between SO~2~ and other gaseous mediators are potential mechanisms for the attenuation of PAH by SO~2~. For example, multiple studies have described the functional interaction between NO and SO~2~ in spontaneous hypertension and atherosclerosis \[[@cit0018]-[@cit0020]\], implying that the presence of other gaseous molecules in the endothelium influences SO~2~ availability and/or efficacy. In this study, we observed that LPS treatment precipitated endothelial injury ([Figs. 9](#f0009){ref-type="fig"} and [10](#f0010){ref-type="fig"}). Thus, the altered availability of NO may have influenced the effects of SO~2~. However, the potential interaction between SO~2~ and NO in PAH induced by LPS needs to be further studied.

Inflammation is also important in the pathogenesis of lung injury caused by LPS \[[@cit0019]\]. In this study, MPO activity in the lung, a marker of tissue neutrophil infiltration, was clearly increased in the LPS groups. ICAM-1 and CD11b are considered to be pivotal for the accumulation of PMNs in the lung, which is a key inflammatory cell type in the development of ALI \[[@cit0003]\]. Stimulation of PMNs by injury-related factors, such as LPS, results in the generation of both inflammatory factors (e.g., IL-1β, IL-6) and anti-inflammatory factors (e.g., IL-10). In this study, SO~2~ could reduce the expression of ICAM-1 and CD11b and activity of MPO, thereby inhibiting IL-1β and IL-6 but enhancing IL-10 generation in the lung. Meanwhile, HDX could significantly augment the expression of ICAM-1 and CD11b and activity of MPO, consequently enhancing IL-1β and IL-6 but inhibiting IL-10 generation in the lung.

Our results suggest that SO~2~ may play a role in regulating the inflammatory response, but this mechanism is unclear and needs further investigation. The mitogen-activated protein kinase (MAPK) pathway is a typical cell signaling pathway that advances inflammatory responses. Here, we examined the expression of Raf-1, MEK-1 and p-ERK/ERK, three main components (arranged in order of activation) in the MAPK pathway, in the lung tissues of LPS-induced ALI rats. Our results indicated that SO~2~ may inhibit the expression of Raf-1 protein, which is upstream of MEK-1 in the signaling pathway. We also found that the phosphorylation of ERK by MEK-1 was down-regulated, resulting in a decreased p-ERK/ERK ratio. These results suggest that SO~2~ inhibits IL-1β and IL-6 but enhances IL-10 generation, likely through the MAPK signaling pathway.

In conclusion, our study suggests that SO~2~ significantly influences the inflammatory response in association with Raf-1, MEK-1 and p-ERK during ALI induced by LPS. Furthermore, it is likely that the down-regulated SO~2~/AAT pathway is involved in the mechanism responsible for lung injury induced by LPS.
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